Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGalliford Try Regulatory News (GFRD)

Share Price Information for Galliford Try (GFRD)

Share Price is delayed by 15 minutes
Get Live Data
522.00    -3.00 (-0.57%)
Bid:
524.00
Ask:
526.00
Spread: 2.00 (0.382%)
Market Cap: £512.62m
GFRD Live PriceLast checked at - London Stock Exchange

Intraday Galliford Try Share Chart

Directorate Change

28 Mar 2024 07:00

RNS Number : 5769I
Galliford Try Holdings PLC
28 March 2024
 

28 March 2024

Directorate Change

 

Galliford Try Holdings plc

Appointment of Chief Financial Officer

 

Galliford Try Holdings plc (Galliford Try or the Group), the UK construction group, is pleased to announce the appointment of Kris Hampson as Chief Financial Officer. He will join the Board no later than September 2024. Kris will replace Andrew Duxbury whose resignation was previously announced.

Kris has a wealth of finance experience and joins from Rentokil Initial plc where he has worked in finance roles for over 16 years. Since 2020 Kris has been Group Financial Controller for the FTSE 100 Group. A senior finance professional with significant experience in listed B2B environments, Kris is a chartered accountant and member of the Institute of Chartered Accountants (ICAEW).

Alison Wood, Chair, said "I am delighted to welcome Kris as the Group's new CFO. Kris has considerable financial experience with a FTSE 100 company and is an excellent addition to the Board. Kris will play a key role in delivering the Group's future growth plans and I look forward to working with him."

Kris Hampson said: "I am delighted to be joining Galliford Try as it continues its impressive performance and sustainable growth strategy. The Group has an incredible history, proven financial performance and the future outlook in its chosen sectors is strong."

A further update will be provided in due course.

This announcement contains inside information.

The Group is holding a Capital Markets Event on 23 May 2024.

No further information is required to be disclosed pursuant to Listing Rule 9.6.13.

 

 

For further enquiries please contact:

 

Galliford Try

Bill Hocking, Chief Executive

Kevin Corbett, General Counsel & Company Secretary

01895 855001

Teneo

James Macey White

 

 

020 7260 2700

Note to Editors

 

Remuneration

 

The remuneration arrangements for Kris Hampson comply with the Director's Remuneration Policy approved by shareholders at its AGM held on 10 November 2023. As the Group's Chief Financial Officer, Kris Hampson's remuneration will comprise:

 

(1) an annual base salary of £380,000.

(2) an annual bonus, subject to performance, of up to 100% of salary of which two thirds of any bonus earned in excess of 50% is deferred into restricted shares for three years.

(3) participation in the Group's long term incentive plan award of up to 150% of salary based on performance over a three year period and subject to a two year holding period post any vesting.

(4) a pension allowance of 8% of salary in line with that offered across the Group's employee population.

(5) a company car or allowance and medical.

 

In accordance with the Director's Remuneration Policy Kris will, over time, build and maintain a shareholding equivalent in value to at least 200% of his salary.

Kris will also receive awards, subject to performance, to compensate for remuneration he is forfeiting on leaving his current employer. These replacement awards will reflect the value of the forfeited awards and the vesting timeline will be the same as those which apply to the forfeited awards. Details will be disclosed in the Group's Directors' Remuneration Report for the year ending 30 June 2024.

 

Galliford Try

 

Galliford Try is a leading UK construction group listed on the London Stock Exchange. Operating as Galliford Try and Morrison Construction, the Group carries out building and infrastructure projects with clients in the public, private and regulated sectors across the UK.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADZGZFVNLGDZM
Date   Source Headline
1st Jun 202610:00 amRNSTotal Voting Rights
29th May 202610:45 amRNSHolding(s) in Company
28th May 20264:10 pmRNSHolding(s) in Company
19th May 20264:00 pmRNSHolding(s) in Company
7th May 20267:00 amRNSInvestor and Analyst Site Visit
1st May 202610:00 amRNSTotal Voting Rights
23rd Apr 202610:30 amRNSReplacement: Completion of Share Buyback Programme
22nd Apr 20267:10 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20264:25 pmRNSContract
20th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20264:15 pmRNSDirector/PDMR Shareholding
13th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 202610:00 amRNSTotal Voting Rights
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20262:30 pmRNSDirector/PDMR Shareholding
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 202610:00 amRNSDirector/PDMR Shareholding
4th Mar 20263:00 pmRNSReplacement - Transaction in Own Shares
4th Mar 20267:00 amRNSHalf-year Financial Report
2nd Mar 202610:00 amRNSTotal Voting Rights
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSContract
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 202610:00 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:02 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.